Neurocrine Biosciences | Capitalización De Mercado



Market Capitalization Cambio Fecha
AbbVie USD 314.02B 34.8B 2024-12
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
Agios Pharmaceuticals USD 1.87B 654M 2024-12
ALKERMES USD 4.65B 123M 2024-12
Alnylam Pharmaceuticals USD 30.35B 4.96B 2024-12
Amgen USD 140.1B 33.03B 2024-12
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Cytokinetics USD 5.55B 661M 2024-12
Dynavax Technologies USD 1.68B 219M 2024-12
Exelixis USD 9.51B 2.11B 2024-12
Gilead Sciences USD 115.12B 10.74B 2024-12
Halozyme Therapeutics USD 6.08B 1.17B 2024-12
Incyte USD 13.31B 576M 2024-12
Intra Cellular Therapies USD 8.87B 1.14B 2024-12
Ionis Pharmaceuticals USD 5.52B 791M 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Repligen USD 8.07B 270M 2024-12
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12



Neurocrine Biosciences Capitalización De Mercado - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.